Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Rises Over 10% Today

Ambalal Sarabhai Enterprises Ltd. Share Price rises 10.31% today, reaching Rs 41.1 with a market cap of Rs 267.22 Cr.

Ambalal Sarabhai Enterprises Ltd. Share Price has experienced a significant rise today, increasing by 10.31% to reach Rs 41.1. This notable price movement positions the company within the Micro Cap category, with a market capitalisation of Rs 267.22 crore. The stock opened at Rs 36.99 and reached a high of Rs 42, reflecting strong investor interest and trading activity.

The rise in Ambalal Sarabhai Enterprises Ltd.'s share price today is a significant event in the context of the company's market position and industry dynamics. As a Micro Cap company, the stock's movement is closely watched by investors seeking opportunities in the Pharmaceuticals & Drugs industry. The data confirms the price event but does not establish a company-specific catalyst, leaving room for further analysis and interpretation.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 41.1
Previous Close	Rs 37.26
Today's Change	+Rs 3.84 (+10.31%)
Day Open	Rs 36.99
Day High	Rs 42
Day Low	Rs 36.99
Current Volume (BSE)	1,20,568
BSE Traded Volume	1,20,568
NSE Traded Volume	6,62,776
Combined NSE + BSE Volume	7,83,344
Turnover	Rs 0.5 crore
Market Capitalisation	Rs 267.22 crore
Market Cap Category	Micro Cap

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) traded at Rs 41.1. versus the previous close of Rs 37.26, a rise of 10.31%. The stock opened at Rs 36.99, reached Rs 42, touched Rs 36.99. Reported volume was 1,20,568.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 267.22 crore
P/E Ratio	16.04x
P/B Ratio	1.8x
ROE	48.74%
ROCE	45.53%
EPS	Rs 2.32
Dividend Yield	0%

Ambalal Sarabhai Enterprises Ltd. was valued at a P/E ratio of 16.04x, a P/B ratio of 1.8x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 48.74% and ROCE of 45.53%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 2.32, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Ambalal Sarabhai Enterprises Ltd. is valued at a market capitalisation of Rs 267.22 crore, with a price-to-earnings (P/E) ratio of 16.04 and a price-to-book (P/B) ratio of 1.8. The company's return on equity (ROE) stands at an impressive 48.74%, while the return on capital employed (ROCE) is 45.53%, indicating strong profitability and efficient capital utilisation.

The company's earnings per share (EPS) is Rs 2.32, reflecting the earnings attributable to each share. Despite a dividend yield of 0, the company's strong ROE and ROCE highlight its ability to generate returns for shareholders. The fundamental analysis suggests that Ambalal Sarabhai Enterprises Ltd. is well-positioned within its industry, with valuation metrics that compare favourably to industry benchmarks.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	16.04x
Benchmark Median P/E	25.88x
Benchmark Average P/E	69.32x
Benchmark P/E Range	3.41x to 3,364.06x
Company P/B Ratio	1.8x
Benchmark Median P/B	1.77x
Company ROE	48.74%
Benchmark Median ROE	10.7%
Company ROCE	45.53%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 267.22 crore
Benchmark Median Market Cap	Rs 146.46 crore

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P/E ratio of 16.04x, which is below the benchmark median of 25.88x, a difference of -38.02%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROE of 48.74%, which is above the benchmark median of 10.7%, a difference of +355.51%. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROCE of 45.53%, which is above the benchmark median of 12.98%, a difference of +250.77%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Ambalal Sarabhai Enterprises Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The company's P/E ratio of 16.04 is below the industry median of 25.88, suggesting a relatively attractive valuation compared to its peers. The P/B ratio of 1.8 is slightly above the industry median of 1.77, indicating a fair valuation in terms of book value.

The company's ROE of 48.74% and ROCE of 45.53% are significantly higher than the industry medians of 10.7% and 12.98%, respectively, highlighting its superior profitability and capital efficiency. With a market capitalisation of Rs 267.22 crore, Ambalal Sarabhai Enterprises Ltd. is positioned below the industry median, offering potential growth opportunities within the sector.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,731.11	0	2.37	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.39	7.98	28.21	26.35
Panacea Biotec Ltd.	PANACEABIO	2,580.49	0	9.08	0	5.36
Beta Drugs Ltd.	BETA	2,474.26	62.88	9.95	18.65	22.17

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P/E ratio of 16.04x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.74% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 45.53% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a market capitalisation of Rs 267.22 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

In comparison to its peers, Ambalal Sarabhai Enterprises Ltd. demonstrates strong financial metrics. The company's P/E ratio of 16.04 is lower than Kwality Pharmaceuticals Ltd.'s 39.39 and Beta Drugs Ltd.'s 62.88, indicating a more attractive valuation. The ROE of 48.74% surpasses that of Hikal Ltd. at 15.22% and Solara Active Pharma Sciences Ltd. at 17.23%, showcasing its superior profitability.

Ambalal Sarabhai Enterprises Ltd.'s ROCE of 45.53% is higher than the industry average, further emphasising its efficient capital utilisation. The company's market capitalisation of Rs 267.22 crore is smaller compared to its larger peers, such as Dishman Carbogen Amcis Ltd. and Hikal Ltd., indicating potential for growth and expansion within the industry.

Why Investors Are Watching Ambalal Sarabhai Enterprises Ltd.

Investors are closely monitoring Ambalal Sarabhai Enterprises Ltd. due to its impressive price rise and strong financial performance. The company's technical indicators suggest positive momentum, while its fundamental metrics highlight robust profitability and efficient capital utilisation.

• Significant 10.31% price rise today.
• Strong RSI indicating positive momentum.
• Impressive ROE and ROCE compared to industry peers.
• Attractive valuation metrics within the sector.

Investors should continue to monitor the company's performance, particularly in terms of its technical indicators and market positioning, to assess potential investment opportunities.

About Ambalal Sarabhai Enterprises Ltd.

Ambalal Sarabhai Enterprises Ltd. is a prominent player in the Pharmaceuticals & Drugs industry, operating within the Healthcare sector. The company is engaged in the development, manufacturing, and marketing of pharmaceutical products, catering to a diverse range of therapeutic areas. With a focus on innovation and quality, Ambalal Sarabhai Enterprises Ltd. aims to deliver effective healthcare solutions to its customers.

The company's business segments include the production of active pharmaceutical ingredients (APIs) and finished dosage forms, serving both domestic and international markets. As a Micro Cap company, Ambalal Sarabhai Enterprises Ltd. is well-positioned to leverage its expertise and expand its market presence within the competitive Pharmaceuticals & Drugs industry.

Track Ambalal Sarabhai Enterprises Ltd. Share Price on Univest

Use Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track the live share price of Ambalal Sarabhai Enterprises Ltd. on Univest, along with key technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and detailed analysis, to help investors make informed decisions.

Frequently Asked Questions

What is the current share price of Ambalal Sarabhai Enterprises Ltd.?

Ans. The current share price of Ambalal Sarabhai Enterprises Ltd. is Rs 41.1, reflecting a 10.31% increase from the previous close of Rs 37.26. The stock moved 10.31% during the session.

How much did Ambalal Sarabhai Enterprises Ltd. share price rise today?

Ans. Ambalal Sarabhai Enterprises Ltd. share price rose by 10.31% today, reaching a high of Rs 42 during the trading session. The stock moved 10.31% during the session. The intraday range extended from Rs 36.99 to Rs 42.

What is the market capitalisation of Ambalal Sarabhai Enterprises Ltd.?

Ans. The market capitalisation of Ambalal Sarabhai Enterprises Ltd. is Rs 267.22 crore, categorising it as a Micro Cap company. The company operates in the Healthcare sector. Its P/E ratio is 16.04x.

What is the P/E ratio of Ambalal Sarabhai Enterprises Ltd.?

Ans. Ambalal Sarabhai Enterprises Ltd. has a P/E ratio of 16.04, which is below the industry median of 25.88, indicating a relatively attractive valuation. The company trades at a P/E ratio of 16.04x.

How does Ambalal Sarabhai Enterprises Ltd.'s ROE compare to industry peers?

Ans. Ambalal Sarabhai Enterprises Ltd.'s ROE of 48.74% is significantly higher than the industry median of 10.7%, showcasing superior profitability. ROE stands at 48.74%. ROCE stands at 45.53%. The relevant peer median ROE is 10.7%.

What sector does Ambalal Sarabhai Enterprises Ltd. operate in?

Ans. Ambalal Sarabhai Enterprises Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.

What is the ROCE of Ambalal Sarabhai Enterprises Ltd.?

Ans. Ambalal Sarabhai Enterprises Ltd. has a ROCE of 45.53%, highlighting efficient capital utilisation compared to industry peers. ROE stands at 48.74%. ROCE stands at 45.53%. The relevant peer median ROE is 10.7%.

How does Ambalal Sarabhai Enterprises Ltd.'s P/B ratio compare to the industry?

Ans. The P/B ratio of Ambalal Sarabhai Enterprises Ltd. is 1.8, slightly above the industry median of 1.77, suggesting a fair valuation. The company trades at a P/E ratio of 16.04x.